SEC FORM 3

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Tehrani Ali

(Last)

(First)

(Middle)

C/O ZYMEWORKS INC.

1385 WEST 8TH AVENUE, SUITE 540

(Street)

VANCOUVER

V6H 3V9

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
01/01/2019

3. Issuer Name and Ticker or Trading Symbol
Zymeworks Inc. [ ZYME ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Executive Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Shares	256,009	D
Common Shares	62,286	I	Held by spouse

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Stock Option (Right to Buy)	01/01/2013⁽¹⁾	01/01/2022	Common Shares	58,660	$5.37⁽²⁾	D
Stock Option (Right to Buy)	01/01/2014⁽¹⁾	01/01/2023	Common Shares	20,950	$7.26⁽²⁾	D
Stock Option (Right to Buy)	01/01/2015⁽¹⁾	01/01/2024	Common Shares	20,950	$11.6⁽²⁾	D
Stock Option (Right to Buy)	01/01/2016⁽¹⁾	01/01/2025	Common Shares	23,464	$14.44⁽²⁾	D
Stock Option (Right to Buy)	01/29/2017⁽¹⁾	01/29/2026	Common Shares	293,300	$12.1⁽²⁾	D
Stock Option (Right to Buy)	02/03/2018⁽¹⁾	02/03/2027	Common Shares	41,900	$22.6⁽²⁾	D
Stock Option (Right to Buy)	06/12/2018⁽¹⁾	06/12/2027	Common Shares	250,000	$9.82	D
Stock Option (Right to Buy)	03/19/2019⁽¹⁾	03/18/2028	Common Shares	250,000	$11.84	D

Explanation of Responses:

1. Stock options vest as follows: (i) 25% of underlying shares on first anniversary of grant date and (ii) remainder of underlying shares in 36 equal monthly installments on last day of month following first anniversary of grant date.

2. Canadian dollars.

Remarks:

Exhibit List - Exhibit 24 - Power of Attorney

	/s/ Daniel Dex, Attorney-in-Fact	01/01/2019
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.